Aaron M. Newman
Researcher Next ID · RN-026962
Researcher · Biochemistry, Genetics and Molecular Biology
California Institute for Regenerative Medicine
San Francisco, India
- Works count
- 239
- Citation count
- 52,237
- H-index
- 53
- i10-index
- 81
Research interests
Publications
Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics
Nature Reviews Molecular Cell Biology · 2024 · 10.1038/s41580-024-00768-2
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma
Nature Medicine · 2022 · 10.1038/s41591-021-01623-z
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma
Cancer Cell · 2021 · 10.1016/j.ccell.2021.08.011
Atlas of clinically distinct cell states and ecosystems across human solid tumors
Cell · 2021 · 10.1016/j.cell.2021.09.014
Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx
Methods in molecular biology · 2020 · 10.1007/978-1-0716-0301-7_7
Single-cell transcriptional diversity is a hallmark of developmental potential
Science · 2020 · https://doi.org/10.1126/science.aax0249
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition
Cell · 2020 · 10.1016/j.cell.2020.09.001
Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer
Gastroenterology · 2019 · 10.1053/j.gastro.2019.10.039
Determining cell type abundance and expression from bulk tissues with digital cytometry
Nature Biotechnology · 2019 · https://doi.org/10.1038/s41587-019-0114-2
The Immune Landscape of Cancer
Immunity · 2018 · https://doi.org/10.1016/j.immuni.2018.03.023
Profiling Tumor Infiltrating Immune Cells with CIBERSORT
Methods in molecular biology · 2018 · https://doi.org/10.1007/978-1-4939-7493-1_12
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
Journal of Clinical Oncology · 2018 · 10.1200/jco.2018.78.5246
Early B cell changes predict autoimmunity following combination immune checkpoint blockade
Journal of Clinical Investigation · 2018 · 10.1172/jci96798
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
Cancer Discovery · 2017 · https://doi.org/10.1158/2159-8290.cd-17-0716
Role of KEAP1 / NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance
Cancer Discovery · 2016 · 10.1158/2159-8290.cd-16-0127
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
Nature Communications · 2016 · 10.1038/ncomms11815
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
Science Translational Medicine · 2016 · 10.1126/scitranslmed.aai8545
Integrated digital error suppression for improved detection of circulating tumor DNA
Nature Biotechnology · 2016 · 10.1038/nbt.3520
The prognostic landscape of genes and infiltrating immune cells across human cancers
Nature Medicine · 2015 · 10.1038/nm.3909
Identification and isolation of a dermal lineage with intrinsic fibrogenic potential
Science · 2015 · 10.1126/science.aaa2151
Robust enumeration of cell subsets from tissue expression profiles
Nature Methods · 2015 · 10.1038/nmeth.3337
FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution
Bioinformatics · 2014 · 10.1093/bioinformatics/btu549
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Nature Medicine · 2014 · 10.1038/nm.3519
clusterMaker: a multi-algorithm clustering plugin for Cytoscape
BMC Bioinformatics · 2011 · 10.1186/1471-2105-12-436
Current projects
No projects listed.